Press Release
Zydus receives final approval from the USFDA for Phentermine Hydrochloride Orally Disintegrating Tablets.30-06-2017
Press Release
Zydus receives final approval from the USFDA for Phentermine Hydrochloride Orally Disintegrating Tablets.Press Release
Zydus' Nesher Pharmaceuticals gets USFDA final approval for Dextroamphetamine Sulfate Extended-Release CapsulesTroubles behind it, Cadila surges ahead
Cadila hopes to double its revenue from the US in three yearsPress Release
Zydus receives final approval from the USFDA for Oxybutynin Chloride Extended-Release TabletsCadila Healthcare Board Nod For Up To Fund Raising Up To Rs 18,500 Crore
Zydus Cadila group has global operations in four continents spread across the US, Europe, Latin America and South Africa and 25 other emerging markets.Focus on Cadila's fund-raising plans
The board of directors of Cadila Healthcare will meet on Monday to consider a proposal to raise funds by issue of equity shares/convertible bonds/debentures through qualified institutional...USFDA closes audit of Zydus' Moraiya facility
Healthcare player Zydus Cadila (Cadila Healthcare Ltd) on Wednesday informed that it had received an audit report from the US drug regulator, the US Food and Drug Administration (USFDA), for the...